🔎 Trials Near Me

Home › Obesity › Wisconsin

Pag-aaral pangklinika para sa Obesity sa Wisconsin

11 pag-aaral para sa Obesity ang naghahanap ng mga kalahok sa mga site sa Wisconsin.

Mga Lungsod sa Wisconsin

Opisyal na teksto ng pag-aaral (English)

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • Ascension Columbia St. Mary's, Milwaukee
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07351045

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Wisconsin Center for Advanced Research, Milwaukee
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Wisconsin Center for Advanced Research, Milwaukee
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06937086

Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)

  • Fortrea Clinical Research Unit Inc. - Madison, Madison
Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07908316

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • Advocate Aurora Saint Lukes Medical Center, Milwaukee
Nagre-recruitPhase 3
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT07037459

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  • Allegiance Research Specialists, Wauwatosa
Nagre-recruitPhase 3
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07684235

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

  • Prevea Health, Green Bay
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07564414

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • Marshfield Clinic, Marshfield
  • Aurora St. Luke's Medi Ctr, Milwaukee
  • Cardio Research & Education Foundation, Wausau
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07567001

Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer

  • Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06106477

Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity

  • Advocate Aurora Research Institute, Milwaukee
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 24, 2026 · NCT07227051

Stand up for Your Health With a Sit-stand Desk

  • Medical College of Wisconsin, Milwaukee
Nagre-recruit
Edad 18 hanggang 79 · Lahat ng kasarian · Na-update May 4, 2026 · NCT05585190

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.